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The abundance of type and quantity of available data in the healthcare field has led many
to utilize machine learning approaches to keep up with this influx of data. Data pertaining to
COVID-19 is an area of recent interest. The widespread influence of the virus across the United
States creates an obvious need to identify groups of individuals that are at an increased risk of
mortality from the virus. We propose a so-called clustered random forest approach to predict
COVID-19 patient mortality. We use this approach to examine the hidden heterogeneity of
patient frailty by examining demographic information for COVID-19 patients. We find that our
clustered random forest approach attains predictive performance comparable to other pub-lished
methods. We also find that follow-up analysis with neural network modeling and k-means
clustering provide insight into the type and magnitude of mortality risks associated with COVID19.
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CHAPTER I: INTRODUCTION
Healthcare in the United States is a constantly and rapidly-evolving industry. The
extensive branches of the industry make the collection and integration of data an important
endeavor. From development and testing of medical treatments or pharmaceuticals to insurance
risk assessment and premium pricing, a wide variety of data is necessary for use by industry
professionals.
A general trend in the current world of information is an increasing abundance and
availability of data. This creates a need for the implementation of methods that can better process
this abundance of data and turn it into useful information. This ever-evolving challenge requires
continual development and integration of data analytics tools. To meet the needs of data
analytics in the healthcare industry, machine learning (ML) approaches have become a topic of
interest [1] [2] [3] [4] [5] [6] [7].
Unquestionably, the most significant challenge to face the healthcare industry in the
United States over the past year has been COVID-19. Since the first confirmed case on January
21, 2020, the United States has seen over 32 million COVID-19 cases that have led to over
578,000 deaths [8]. Predicting the spread and severity of COVID-19 is an obvious area of
interest.
A recent area of interest in the study of COVID-19 has been on those individuals at
particular risk from COVID-19. According to Aizenman [9], treatment of individuals with
compromised immune systems may shape the way the virus runs its course:
“There's mounting research to suggest that protecting people who are immunocompromised from getting COVID is important not just for their sake – it could be
critical in the effort to end the pandemic for everyone'' [9].
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For example, immuno-compromised individuals may not react to treatments in the same manner.
In examining HIV-positive individuals who had been vaccinated against COVID-19, Dr. Laura
McCoy, an infectious disease researcher at University College in London, remarked: ''we
couldn't actually see any measurable levels of anti-coronavirus antibody in the blood'' [9]. These
immuno-compromised individuals may also create avenues of risk for the general population. Dr.
Salim Abdool Karim of South Africa's Centre for the AIDS Programme of Research noted that
the increased time immuno-compromised individuals may be infected with COVID-19 creates
added risk, noting that a particular HIV-positive woman ''became a cauldron for the creation of a
whole lot of new variants'' [9]. It is apparent that identifying certain groups at an increased risk
from COVID-19 could be important in curtailing the spread of the virus.
To aid in evaluating and modeling the course of COVID-19, ML methods have been
employed. Wang and Wong [10] utilized a neural network approach on chest X-ray images to
identify COVID-19 cases. Pal et al. [11] developed country-specific neural network models to
determine a country’s COVID-19 risk. In Liu et al. [12], the authors use ML approaches to
predict the spread of COVID-19 in Chinese provinces. The authors in Beck et al. [13] propose a
list of drugs to possibly combat COVID-19 identified from a deep learning model. A generative
adversarial network was built by Khalifa et al. [14] to identify COVID-19 linked pneumonia
from chest X-ray images. Sujath et al. [15] attempt to forecast the spread of COVID-19 in India
using multilayer perceptron and vector autoregression methods.
The random forest (RF) is an approach in ML that has shown merit in accurately
modeling COVID-19 outcomes. The RF approach utilizes an ensemble of weak decision tree
classifiers to make predictions. The RF approach has been used somewhat commonly to model
the COVID-19 pandemic. Tang et al. [16] built a RF model to predict the severity of a COVID-
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19 diagnosis from chest CT images. Barbosa et al. [17] utilized a RF classifier to diagnose
COVID-19 from blood samples. Gupta et al. [18] predicted cases of COVID-19 in India with a
RF model. The RF model was also employed by Yesilkanat [19] to predict COVID-19 case
counts at the country level. An effort to predict COVID-19 health outcomes from demographic
and medical information in Korea was made by the authors in An et al. [20]. A similar effort to
predict COVID-19 health outcomes for patients in Wuhan using RF methods was made by Wang
et al. [21]. Majhi et al. [22] also utilized a RF model to predict COVID-19 case counts. Iwendi et
al. [23] set out with the goal of identifying a modeling approach that worked best for COVID-19
patient health outcome prediction. The authors utilized the RF method with the AdaBoost
boosting algorithm to predict COVID-19 mortality at the individual level. Demographic
information for individuals that contracted the virus was used to predict if a patient would die.
The authors compared several common modeling approaches and determined that the boosted
RF model was the best.
While the RF method is generally praiseworthy for its prediction performance, it does
have limits in explaining why certain predictions were made. The RF method does not assume a
structure for the data, so it can be difficult to assess how and why certain features of the data
affect predictive performance.
One challenge with COVID-19 is the somewhat varied effects that it can have on an
individual. Whether it be individuals in different age groups or races, it is apparent that COVID19 affects certain groups quite differently [24]. To this end, it could be beneficial to explore the
differing risks that individuals have in the context of exposure to COVID-19. In the
aforementioned work on COVID-19 patient health prediction, the models were developed using
the full body of selected data. This could be in part due to the lack of available data. Given the
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differing effects of COVID-19 on certain demographic groups, an exploration into modeling
approaches that cater to these different effects seems worthy of investigation.
This idea of using individual patient characteristics to predict health outcomes
underscores a current research trend in the healthcare industry: personalized medicine [25] [26]
[27] [28]. The interest here is to use information about an individual to predict health outcomes.
To better predict a patient’s health outcome, the main hook with an individualized model
is the discernment with which a predictive model is built. Rather than using a predictive model
that has been built using all available patients, a personalized model would be built using only
those patients who are similar to the individual that is being assessed.
Building a model using only individuals similar to a patient in question obviously
necessitates a way to define patient similarity. As the success of a personalized model may be
heavily dependent on selecting appropriate individuals from which to build the model,
appropriately defining a similarity measure is an important step.
Some different approaches have been utilized to measure patient similarity. Park et al.
[29] used a so-called statistical case-based reasoning approach to identify similar patients. A
clustering approach was used to identify similar patients by Panahiazar et al. [30]. A propensity
score approach was utilized by Brookhart et al. [31] to define patient similarity.
Interestingly, a RF methodology can be employed to define a similarity measure. Lee
[32] used RF methods to develop a patient similarity measure for ICU patients. Running a RF
model in an unsupervised manner (with no prediction goal in mind) gives a similarity score
between individuals. This similarity measure allowed a RF model to be developed for individual
patients using only similar patients in the model-building process. The author found that the RF
methods employed performed better than other common models to predict ICU patient mortality.
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This paper intends to explain and implement a method to predict COVID-19 patient
health outcomes using RF methods while concurrently giving insight into the different risks that
different demographic groups face from COVID-19. As a note, we are eschewing more
traditional approaches, such as principal components analysis, in favor of RF methods for the
ability to better interpret our features. We will use the boosted RF model shown by Iwendi et al.
[23] to be a reasonable standard for addressing prediction performance for COVID-19 patient
mortality as a benchmark for predictive performance. We will also incorporate the RF patientsimilarity measure utilized by Lee [32] as a tool to examine the qualities that affect COVID-19
risk. A neural network model and k-means clustering will both be used as methods for follow-up
work to better understand the conclusions drawn from the RF modeling. This work will show
that a RF model that utilizes preliminary clustering by patient similarity can achieve prediction
performance competitive with other methods while also providing qualitative information about
feature effects that are typically hard to get at with RF methods.
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CHAPTER II: MATERIALS AND METHODS
Modeling for this project was done in R version 3.6.1. The randomForest [33] R package
was used for building RF models. The adabag [34] and cluster [35] packages were used for
implementing the AdaBoost algorithm and cluster analysis, respectively. The neuralnet [36]
package was used for building the neural network model.
For this project, the data were sourced from the CDC’s case surveillance data [37]. This
dataset contains observations of over 22 million occurrences of COVID-19 in the United States
with 32 features. The observations range in time from as early as January 1, 2020 to as late as
March 30, 2021. A summary of these data tells us that only about 5% of individuals observed
died from COVID-19. This unbalanced distribution of surviving and dying observations is
important to note for putting future evaluation metrics into context. To ease the computational
burden for this project, a sample of 10,000 individuals was randomly selected from the CDC data
to be used in this project. Additionally, due to the presence of many missing values for some data
features, a selection of 10 features were used for our analysis. The utilized features can be seen
in Table 2.1. Additionally, date features were converted to numeric features to accommodate
formatting for the utilized R packages.
Table 2.1: Features selected for analysis and their descriptions.
Feature
race_ethnicity_combined
cdc_case_earliest_dt
cdc_report_dt
sex
onset_date
hosp_yn
death_yn
medcond_yn

Description
Race and Ethnicity (combined)
Earliest available date for record
Initial date case reported to CDC
Patient sex
Date of symptom onset
Patient hospitalized
Patient died
Patient had pre-existing condition
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Levels
8 levels
NA
NA
Male, Female
NA
Yes, No
Yes, No
Yes, No

Type
Categorical
Date
Date
Categorical
Date
Categorical
Categorical
Categorical

Feature
res_state
age_group

Description
State of residence
Patient age group

Levels
50 levels
8 levels

Type
Categorical
Categorical

Our method for predicting COVID-19 patient mortality in this project relies heavily on
the random forest (RF) classifier from Breiman [38]. The RF classifier is itself made up of many
decision trees. A decision tree classifier is made by successively splitting our data at decision
nodes according to feature values. Our initial decision node splits the data into two groups
according to a cutoff value for one of the data features. Then these groups are again split by a
decision node, and this process continues, building out the “branches” of the decisions tree.
When the splitting stops, the last remaining groups, or “leaves” of the decision tree provide the
designation for which class individuals in that group belong. The feature used at each decision
node to split the data is typically chosen so that error at that step is minimized. An example of a
classification decision tree may be seen in Figure 2.1. The RF classifier uses an ensemble
“forest” of these decision trees to make its classifications.
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Figure 2.1: A decision tree classifier for classifying observations into three classes: 1, 2, and 3.

A decision tree classifier for classifying observations into three classes: 1, 2, and 3.
Each tree in the RF ensemble is built using a bootstrapped random sample of the available data
and considering only a random selection of available features when each splitting node is made.
To classify an observation with the RF model, each decision tree in the ensemble “votes” for the
class it predicts and the majority vote of the decision trees in the ensemble is the class that the
RF classifier predicts. This reliance on the majority vote to classify an observation provides for
better performance than a single decision tree classifier.
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The authors in Iwendi [23] et al. elect to use boosting to improve the RF prediction
results. The AdaBoost method the authors use works by building a sequence of RF models with
misclassified observations given more weight for each RF model in the sequence. Overall
classifications are given with an aggregate of the model iterations.
We take a different approach to improve the RF model. As Lee [32] did, the RF classifier
can create a similarity measure if used in an unsupervised manner. This is done by building fake
observations from the available data. The RF classifier is then used to classify the data as real or
false. A similarity measure between any two observations from the real dataset is taken to be the
proportion of the time those two observations ended up in the same leaf of a decision tree in the
RF ensemble. From Lee, we may then denote the similarity between a patient i and a patient j,
call it SIM(i,j), by
,

=

,

, = 1, … , , = 1, … , , ≠ , ≠ .
,

Here Prox(i,j) is the number of trees in the RF ensemble that have both i and j in the same
terminal node, or "leaf." If calculated for every pair of patients, we can develop a similarity
measure for all considered observations.
This similarity measure can be used to cluster the data into similar groups. We will be
using the PAM algorithm implemented with the clara function in the cluster R package to group
our data. The appropriate number of clusters can be tuned by looking at the average silhouette
for observations in a cluster. For each observation, the silhouette width is defined as the
minimum average dissimilarity of that observation compared to each other cluster. Thus a high
average silhouette width indicates that a cluster is different from the other clusters. That is, a
high average silhouette width indicates that clusters are distinct, as desired.
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We will now discuss the methodology that will be used for the analysis in this paper,
which will be referred to as the "Clustered RF" method. The clustering described earlier will be
used as a preliminary step to building our model. The clustering will be performed to partition
the observations according to the highest average silhouette width, and then on each cluster, a RF
model will be built to predict patient mortality. The classifications for the overall model will
simply be the classifications given by the RF classifier built on each cluster. In this way,
classifications for patients in a cluster will be based on information from the patients similar to
them also in that cluster.
Given the skew of the data toward surviving observations, Iwendi [23] et al. chose to use
several metrics to evaluate predictive performance. We will use those same metrics in our
evaluation. These measures are based on True Positives (TP), True Negatives (TN), False
Positives (FP), and False Negatives (FN) and are given now.
Accuracy

=

Precision

=

Recall

=

F1 Score

=

TP + TN
TP + TN + FP + FN
TP
TP + FP
TP
TP + FN
Precision × Recall
2×
Precision + Recall

Given the small proportion of individuals who did die from COVID-19 in the available
data, these measures give a better picture of how powerful a model is in correctly predicting
mortality.
As we will see during our discussion of the results of the clustered RF method, the added
risk that we are able to derive is a somewhat crude measure that does not take into account the
risk associated with membership into multiple groups simultaneously. To get at the interaction
between levels of different factors, a neural network model is used on the data as well. The
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neural network approach is described in [39]. The neural network is built by deriving new
features (these features are thought of as a hidden layer) that are linear combinations of the
original features that have been passed through an activation function. Then the variable we wish
to predict is modeled as a function of linear combinations of the derived features. A
representation of the neural network model is seen in Figure 2.2 (from [39]). The bottom row is
the original data features.

Figure 2.2: An example of a neural network model.
The middle row is the hidden layer of derived features, and the top row is the variable we
wish to predict. Fitting such a neural network model then requires the selection of the number of
derived features in each hidden layer and the weights used to create the aforementioned linear
combinations. Additionally, an appropriate activation function must be specified. The
methodology for the fitting of the model is not a focus here, and we will not venture into the
specifics. The takeaway here is that we will be using the neural network model to get the

11

probability that an individual with certain characteristics that we specify will die from COVID19.
After observing the clusters that we obtain throughout the rest of this paper, a look at how
discriminatory certain features of our data are in determining which individuals are clustered
together will be a nice addition. To this end, we incorporate a k-means clustering of our data.
This method clusters observations so as to minimize the sum-squared distance measure of each
observation to its assigned cluster.
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CHAPTER III: RESULTS
As a test of efficacy, the clustered RF method was performed on the data used by Iwendi
[23]et al. using a partition of three clusters. The target feature to predict was patient mortality.
To build each cluster’s RF model, the randomForest command in the same-named R package
was used with ntree=1000 and mtry=3. The evaluation metrics for the clustered RF method
compared to the metrics obtained by the boosted RF method may be seen in Table 3.1.
Table 3.1: Accuracy, Precision, Recall, and F1 Score for the prediction of patient mortality on
the data used by Iwendi et al. [23].
Model
Accuracy Precision Recall F1-score
Boosted RF 0.94
1
0.75
0.86
Clustered RF 0.92
0.93
0.93
0.93

The clustered RF and the AdaBoost RF method were then performed on the CDC case
surveillance data. Four clusters were used, as this number of clusters gave the highest average
silhouette width of the considered values of 2:8. The target feature to predict was death_yn. To
build each cluster’s RF model, the randomForest command in the same-named R package was
used with ntree=1000 and mtry=3. The evaluation metrics for these models may be seen in
Table 3.2.
Table 3.2: Accuracy, Precision, Recall, and F1 Score for the prediction of patient mortality on
CDC case surveillance data.
Model
Accuracy Precision Recall F1-score
Boosted RF 0.95
0.59
0.40
0.48
Clustered RF 0.95
0.61
0.38
0.47

For the 4 clusters that our data was partitioned into, we have broken down the proportion of
individuals that fall into each level of the features and compared them to the overall makeup of
the sample of 10,000. We see these in Tables 3.3, 3.4, 3.5, 3.6.
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Table 3.3: Percentage of individuals who fall into health categories for overall sample of 10,000
and for each of the 4 clusters. Given as percentages. For the first three features, the number is not
a percent, but the mean value.
Cluster cdc_case_earliest_dt cdc_report_dt onset_dt pre-existing hospital died
Overall 266.04
281.77
267.58
46.34%
16.48% 5.62%
1
267.90
282.99
269.72
50.03
15.63
4.37
2
233.17
248.60
234.94
2.34
0
0
3
99.17
145.63
99.43
100
99.38
47.84
4
399.21
400.46
399.21
0
0
0

Table 3.4: Percentage of individuals who fall into racial categories for overall sample of 10,000
and for each of the 4 clusters. AI/AN is American Indian/Alaska Native, and NH/PI is Native
Hawaiian/other Pacific Islander. Given as percentages.
Cluster AI/AN Asian Black Hispanic Multiple NH/PI White
Overall 0.24% 2.88% 9.14% 20.4%
3.62%
0.42% 63.3%
1
0.24
2.74
9.45
21.46
3.52
0.46
62.13
2
0
0.78
1.17
8.20
2.73
0
87.11
3
0
4.94
24.69 23.46
4.01
0
42.90
4
0
2.26
3.39
14.25
2.94
0
77.15
Table 3.5: Percentage of individuals who fall into age categories for overall sample of 10,000
and for each of the 4 clusters. Given as percentages.
Cluster 0-9
10-19 20-29
30-39
40-49 50-59 60-69 70-79 80+
Overall 3.18% 9.8% 16.48% 15.08% 14.4% 15.2% 12.6% 8.08% 5.18%
1
2.92
7.61 14.95
15.24
15.72 16.72 13.02 8.63
5.18
2
2.15
28.71 46.48
10.74
6.25
3.71
1.76
0.20
0
3
0
0.31 3.09
4.94
6.48
21
26.54 15.74 21.91
4
11.54 30.32 18.55
22.62
12.67 4.07
0.23
0
0
Table 3.6: Percentage of individuals who fall into sex and geographic categories for overall
sample of 10,000 and for each of the 4 clusters. Given as percentages.
Cluster Female Male
Northeast Midwest South West
Overall 54.12% 45.88% 17.54%
53.86% 5.34% 23.26%
1
54.53
45.47
15.85
52.68
5.81
25.66
2
54.88
45.12
9.38
89.06
0
1.56
3
42.28
57.72
77.78
12.35
8.33
1.54
4
51.36
48.64
16.29
66.74
0
16.97
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A neural network model was built for the CDC case surveillance data. Using the
neuralnet command in R with hidden=3, threshold=0.1, and all others default. A logistic
activation function was used with death_yn as the prediction target, coded 0 for no death and 1
for death. As a note, the goal of this follow-up was to compare mortality rates for a variety of
different individual characteristics. During the initial run, the hosp_yn feature proved to be too
strong of a factor in predicting death to make the results easily interpreted. Since we want to
compare relative risk of individuals with different characteristics, this feature was removed for
the neural network model results we will be discussing. Using the neural network model, a
selection of mortality rates were calculated for individuals with characteristics of interest. These
results can be seen in Tables 3.7, 3.8, 3.9, 3.10.
Table 3.7: Neural network-estimated probabilities of death for a white male with no pre-existing
conditions by region and age group. Given as percentages.
Age
10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+
Northeast 0.29 0.33 0.38 0.36 0.94 2.48 5.19 9.41
Midwest 0.31 0.33 0.41 0.34 0.93 2.04 3.26 5.36
South
0.02 0.36 0
0.56 3.62 21.09 8.51 28.46
West
0.32 0.33 0.48 0.33 1.21 2.49 3.05 4.32
Table 3.8: Neural network-estimated probabilities of death for a black male with no pre-existing
conditions by region and age group. Given as percentages.
Age
10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+
Northeast 0.32 0.33 0.7
0.35 2.35 5.11 6.18 8.7
Midwest 0.32 0.33 0.53 0.34 1.44 2.97 3.46 4.73
South
0.26 0.39 1.7
0.5
7.5
16.27 23.32 35.47
West
0.32 0.33 0.5
0.33 1.25 2.48 2.72 3.55
Table 3.9: Neural network-estimated probabilities of death for a hispanic male with no preexisting conditions by region and age group. Given as percentages.
Age
10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+
Northeast 0.3
0.34 0.59 0.36 1.92 4.44 6.59 10.44
Midwest 0.31 0.33 0.5
0.34 1.35 2.91 3.88 5.81
South
0.12 0.38 0.1
0.56 0.95 4.62 17.5 35.5
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Age
West

10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+
0.32 0.33 0.52 0.33 1.39 2.85 3.31 4.52

Table 3.10: Neural network-estimated probabilities of death for an asian male with no preexisting conditions by region and age group. Given as percentages.
Age
10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+
Northeast 0.29 0.34 0.67 0.38 2.51 6.14 9.07 14.68
Midwest 0.31 0.33 0.57 0.35 1.76 3.93 5.42 8.28
South
0
0.41 0
0.68 48.68 51.87 63.73 42.9
West
0.32 0.33 0.61 0.34 1.87 3.98 4.68 6.47
The kmeans R command was used to cluster our data into 4 clusters. The number of
clusters was chosen both because it is the same number used in the RF clustering and because the
useful distinction amongst clusters in regards to death rate seemingly began to deteriorate when
more clusters were used. We project our data onto the two-dimensional axis, seen in Figure 3.1.
The same data plotted with the four cluster labels is seen in Figure 3.2. Our interest in this
clustering application was looking at which features of the data were most discriminatory in
determining membership in a certain higher risk group. To this end, we plotted the proportion of
certain feature levels by membership in the four clusters, which we see in Tables 4.9, 4.10, 4.11,
4.12.
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Figure 3.1: Density plot of observations projected onto the 2-dimensional plane. Top in red are
deaths, and bottom in blue are survivors.
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Figure 3.2: Density plot of observations projected onto the 2-dimensional plane. Cluster 4 is the
high death rate cluster.
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CHAPTER IV: DISCUSSION
Our aim in the implementation of the clustered RF is not to sacrifice predictive power.
Consequently, it is important that our clustered RF approach performs comparably to the
AdaBoost RF method determined by Iwendi et al. [23] to be a benchmark for COVID patient
predictive models. We see from the comparison metrics in Table 3.1 that the clustered RF
method does seem to perform comparably to the boosted RF. The Boosted RF model is superior
in Accuracy and Precision, but the Clustered RF performs better in Recall and F1-score. It is fair
to say that the clustered RF method is not an obvious step backwards. This gives a positive
indication that the preliminary clustering can replace the boosting algorithm and give similar
prediction performance. The comparison metrics for the clustered RF and the boosted RF on the
CDC data seen in Table 3.2 yield similar results. The clustered RF seems to perform comparably
to the AdaBoost method, with all compared metrics being within 0.02 of each other.
We do note that the performance of both methods on the CDC data is obviously much
worse than the performance on the data from Iwendi et al. [23]. This is a bit troubling, but a
deeper dive into the data used by those authors provides a possible explanation. Upon inspection
of the data used, it is noteworthy that the deaths in these data have strong correlation with the
patient being from a certain location. For example, 39 of the 63 reported death in these data came
from China, and those 39 deaths were out of the total of 42 observations from China. It is then
possible that this and other similar trends in the data created an unrealistic picture of correlation
between country of origin and mortality. This has possibly created the capacity for the RF
method to provide a prediction accuracy beyond what might be expected from a larger dataset,
such as that provided by the CDC.
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Having established that the clustered RF method meets a reasonable standard of
predictive performance, it becomes reasonable to now look at the benefit of the clustering
approach. While RF methods typically provide a lesser ability to look at how certain predictors
influence predictions compared to parametric methods, this clustering approach provides an
avenue to gain some insights in this regard. The cluster analysis grouped our 10,000 observations
into four groups. Naturally, some of these clusters will have mortality rates higher than the
overall mortality rate for the 10,000 observations, and some of these clusters will have mortality
rates lower than the overall. By examining how clusters vary by death rate, we can attempt to
gain some information about the characteristics of individuals at a higher risk of death from
COVID. These trends may be compared against trends that have been noted by the CDC to see if
the insights given by the clustering RF model could be reasonably trusted.
Note that in Table 3.3, cluster 1 has a death rate of 4.37%, which is the closest of the four
clusters to the overall death rate of 5.62%. This fits a general trend we see for cluster 1. For
every feature in this project, cluster 1 stays close to the makeup of the overall sample. In no
obvious way does cluster 1 distinguish itself from the whole. Consequently, we will be focusing
on clusters 2-4 to gain insight into the variable risk of COVID-19. The mortality rates for
individuals in Clusters 2-4 are drastically different from the overall mortality rate of 5.62%.
Clusters 2 and 4 did not have any deaths, while cluster 3 had a death rate of 47.84%. The natural
inclination then is to view clusters 2 and 4 as low-risk clusters, and cluster 3 as a high-risk
cluster with the intention of discerning characteristics of the individuals who reside in these
clusters.
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Figure 4.1: Percentage of individuals who fall into health categories for overall sample of
10,000 and for each of the 4 clusters. Same information as in last three columns of Table 3.3.
First, let us turn our attention to the features from Figure 4.1. We note that clusters 2 and
4 both had no patients that were hospitalized and a very low percentage of patients with preexisting conditions. Cluster 3 had close to 100% of individuals hospitalized and having preexisting conditions. This is in line with the risk of pre-existing conditions outlined by the CDC
[40].
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Figure 4.2: Percentage of individuals who fall into racial categories for overall sample of 10,000
and for each of the 4 clusters. AI/AN is American Indian/Alaska Native, and NH/PI is Native
Hawaiian/other Pacific Islander. Same information as in Table 3.4.
In Figure 4.2, we find the racial breakdowns for the four clusters. We can find a clear
picture here. The high-risk cluster 3 is over-represented with individuals of Asian, Black,
Hispanic, and multiple ethnicity and under-represented in White individuals. The low-risk
clusters 2 and 4 show the opposite trend, both having more White people and fewer of all other
groups. It is clear that minority groups are much more abundant in these high-risk clusters and
obviously less abundant in the low-risk clusters. This is a compatible conclusion with some of
the risk factors also outlined by the CDC [24].
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Figure 4.3: Percentage of individuals who fall into age categories for overall sample of 10,000
and for each of the 4 clusters. Same information as in Table 3.5.
We can also look at the age demographics in Figure 4.3. A general trend to note is that clusters 2
and 4 have a lower percentage of individuals in age groups above 39 than the overall, while
cluster 3 has more individuals in the age categories above 49. Cluster 3 also has fewer
individuals from all age groups 49 and younger. The trends for clusters 2 and 4 are less obvious
in the younger age groups, but the general trend of older individuals being at greater risk follows
some of the notions put forth by the CDC [40].
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Figure 4.4: Percentage of individuals who fall into sex and geographic categories for overall
sample of 10,000 and for each of the 4 clusters. Same information as in Table 3.6.
Finally, in Figure 4.4, we have sex and geographic region breakdowns. Cluster 3 has
relatively more males than overall and more people from the Northeast and South. There are also
fewer people from the Midwest in cluster 3, while the percentage of people from the West is
close to 0. Clusters 2 and 4 have sex proportions similar to the overall but noticeably have more
people from the Midwest and no people from the South. Here we seem to have highlighted both
being Male and being from the Northeast or South as possible added risk factors for COVID-19
mortality.
Given the absence of an assumed structure placed on our data by the RF method,
calculating added risk factor by membership is not a straightforward task. However, we can
obtain a somewhat crude measure by calculating how likely an individual is to find themselves in
one of our clusters. For example, to calculate the added risk associated with being male, we look
at how males are distributed among the clusters and calculate how likely a male is to fall into
each cluster. We then multiply by the likelihood that an individual dies in each cluster to get how
likely a male is to die. While this calculation ignores the interaction of other factors, it can give a
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general idea of what is happening. We look at a calculation of added risk for a selection of
factors in Table 4.1. We see similar trends to what we might expect with minority groups and
older individuals having added risk, with males and the Northeast and South also being identified
as risk factors to COVID-19 mortality.
Table 4.1: Average added risk of mortality from COVID-19 for membership in a certain feature
level, as compared to the overall mortality rate of 5.62%. Given as percentages.
Factor Level
Added Risk
Asian
+1.11%
Black
+2.41%
Hispanic
White
Female
Male
Pre-existing Condition
50-59 yrs
60-69 yrs
70-79 yrs
80+ yrs
Northeast
Midwest
South
West

+0.13%
-0.84%
-0.56%
+0.09%
+1.73%
+0.54%
+1.75%
+1.50%
+4.65%
+4.70%
-1.54%
+0.95%
-1.31%

The method we used to estimate added risk from the RF clusters has the drawback of not
providing an assessment of added risk for more than a single factor level at a time. For example,
the RF calculation only provided an added risk of 4.7% for living in the northeast. It would be
worth investigating if this risk affected all individuals from the northeast equally or if certain
groups felt the detrimental effect of living in the northeast more strongly. To this end, we
performed mortality prediction using the neural network model. Specifically, we looked at risk
for individuals from several racial groups by region and age group. We looked at male
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individuals with no pre-existing conditions to focus on the possible different effect that region
would have on race and age group mortality. We have the mortality estimates for white, black,
Hispanic, and Asian individuals in Figures 4.5, 4.6, 4.7, and 4.8 respectively.

Figure 4.5: Probability of mortality for a white male with no pre-existing conditions for certain
age groups in years. Given as a decimal. Same information as in Table 3.7.
One overarching trend is that the effect of region seems to be hidden in the earlier age
groups. For all four races, the mortality rates for earlier age groups are indistinguishable by
region. However, at the later age groups, we see that the mortality seems to increase for the south
and northeast regions, compared to the midwest and west. We also note that for the younger age
groups the higher risk for the black, Hispanic, and Asian groups that was detected earlier does
not show up either. A reasonable explanation for this phenomenon would be that health
outcomes for younger individuals are not dependent on medical intervention, and, consequently,
any disparity in mortality due to differing quality or access to healthcare caused by membership
in a racial or regional group does not show up for those younger individuals.
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Figure 4.6: Probability of mortality for a black male with no pre-existing conditions for certain
age groups in years. Given as a decimal. Same information as in Table 3.8.
Interestingly, we do see the influence of racial groups appear differently for the later age
groups. The mortality rates for non-white individuals in the older age groups do tend to be higher
than the mortality rates for white individuals in the same age groups. Additionally, the detriment
associated with living in the northeast or south takes effect earlier in the non-white race groups.
For example, a white individual does not see the northeast detriment until the age 70-79 age
group, while the other racial groups see this departure start to occur in the 50-59 or 60-69 age
groups. We also see that Hispanic individuals do not have especially worse mortality risk for
living in the south until the 70-79 age group, contrary to the other age groups.
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Figure 4.7: Probability of mortality for a hispanic male with no pre-existing conditions for
certain age groups in years. Given as a decimal. Same information as in Table 3.9.
Another obvious trend is the unrealistically high mortality risk for the south for many of
the older age groups. The south was one of the lesser reported regions in our data, and it is quite
possible that we have some reporting bias, with possibly only the most severe cases being
reported and contributing to these extreme predicted mortality rates. It should be kept in mind
that the focus for these predicted mortality rates is to look at the heterogeneity of risk factors,
rather than getting the most accurate mortality prediction.
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Figure 4.8: Probability of mortality for an Asian male with no pre-existing conditions for certain
age groups in years. Given as a decimal. Same information as in Table 3.10.
The general trend we see when plotting the data in a two-dimensional manner, as in
Figure 3.2, is that the deaths are more heavily populated on the bottom left side of our plane.
However, we do note that both deaths and survivors are found throughout the covered area of the
plane with no real way to separate them into two neat clusters. Consequently, the features
available to us are not discriminating factors in determining whether or not an individual dies
from COVID-19. Despite this, clustering into 4 clusters, as seen in Figure 3.3, does get us
somewhere. Cluster 4, seen toward the left of the plane in purple, is quite distinct from the other
three clusters in terms of mortality. This cluster has a death rate of about 17%, while the other
three clusters have death rates from around 2% to 4%. We can then look at how certain features
are distributed amongst the 4 clusters to get a sense of what features determine membership in a
cluster. We see these breakdowns in Figures 4.9, 4.10, 4.11, 4.12. The general trend we see is
unsurprising. We see younger individuals under-allocated and older individuals over-allocated to
the high-risk cluster. Also, males, non-white individuals, and individuals with pre-existing
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conditions are over-allocated to the high-risk cluster. This makes sense, as our previous work has
identified these as areas of risk for increased mortality.

Figure 4.9: Proportion of individuals in each age group by cluster. Cluster 4 was the highmortality cluster.

Figure 4.10: Proportion of individuals in each sex group by cluster. Cluster 4 was the highmortality cluster.
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Figure 4.11: Proportion of individuals in each race group by cluster. Cluster 4 was the highmortality cluster.

Figure 4.12: Proportion of individuals in each medical condition group by cluster. Cluster 4 was
the high-mortality cluster.
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CHAPTER V: CONCLUSION
In this project, we set out to predict COVID-19 patient mortality using demographic data
from patients in the United States. The Random Forest method was an attractive machine
learning approach that had already been utilized for similar purposes. In fact, the AdaBoost
boosted random forest had been established as the method that gave superior predictive
performance when compared to several common techniques. While predictive performance is
important, we were interested in the heterogeneity of COVID-19 risk factors. That is, we wanted
to look at risk factors beyond the typically noted ones, such as having a pre-existing medical
condition or being in an older age group.
Given the lack of structure that RF methods impose on the data, getting this information
required the incorporation of additional tools. To this end, we incorporated a patient similarity
measure that was derived from using a RF classifier in an unsupervised manner. This gave us a
similarity measure between patients that allowed us to cluster our observations into 4 clusters.
By building a RF classifier separately on each cluster, we hoped to make up the predictive
performance gained by using the AdaBoost algorithm while simultaneously figuring out a way to
get at how certain factors put some groups at higher risk of death from COVID-19.
The clustering approach did seem to pay off in prediction performance, as our approach
yielded prediction performance metrics that were all within 0.02 of the Adaboost method.
Additionally, the clusters did provide insight into factors affecting risk of mortality from
COVID-19. We were able to look at which clusters were at higher or lower risk of death and
note which demographic groups were over or under-represented in these clusters. The identified
factors did in general mesh with conclusions put out by the CDC.
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To better get at the intricacies of the added risk measure produced by the clustered RF
approach, we built a neural network model to predict patient mortality. When this model was
used to estimate risk for individuals from different racial, regional, and age groups, we did
expose some hidden heterogeneity. The risk associated with a certain region, for example, did
not affect all races or age groups equally. This neural network model certainly exposed the
complexity in estimating COVID-19 mortality risk.
With the wide range of outcomes associated with COVID-19 infection, a way to assign
some kind of order to the severity of outcome was needed. To this end, we utilized k-means
clustering, along with a way to project the multi-dimensional observations onto the twodimensional plane. This approach did shed some light on how discriminatory our features were
in predicting COVID-19 mortality. While our density plots did show a general trend of death
observations showing up more heavily in one area, our observations were far from being able to
be neatly clustered into a survivor group and a death group. However, the subsequent clustering
did produce a distinctly high-risk cluster whose membership seemed to be determined by the
identified mortality risk factors.
In addition to providing some insight into the hidden heterogeneity of COVID-19
mortality risk, this project has seemingly succeeded in showing that RF methods when
approached from a different angle can provide valuable insight into how certain features of data
affect the prediction problem at hand. Specifically, our results could be used as a guide for which
communities most need resources to combat COVID-19. We see clear trends of older, minority
individuals in the northeast and south as being at an elevated risk of mortality from COVID-19,
and this information should prompt a focus on these individuals.
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The ability to achieve good prediction performance and also get qualitative information
about features of the data make a clustered RF approach worthy of exploration in similar
problems. This approach could be used as a starting point to look at how certain features
influence a dependent variable in cases where less is known at the outset. Further work in how
the clustering is performed from the similarity measure developed from the RF method would be
warranted. Only two methods to cluster the data were utilized in this project, and it is certainly
possible that more creative ways to perform clustering might yield interesting results.

Disclaimer: The CDC does not take responsibility for the scientific validity or accuracy of
methodology, results, statistical analyses, or conclusions presented.
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APPENDIX A: CODE AVAILABILITY
Code Availability: R code for this work may be accessed at
https://github.com/edcorne/Cornelius-MS-Thesis-Summer-21-Illinois-State-University.git.
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